1
|
Vohradsky J, Tran LT, Guatelli S, Chartier L, Vandevoorde C, de Kock EA, Nieto-Camero J, Bolst D, Peracchi S, Höglund C, Rosenfeld AB. Response of SOI microdosimeter in fast neutron beams: experiment and Monte Carlo simulations. Phys Med 2021; 90:176-187. [PMID: 34688192 DOI: 10.1016/j.ejmp.2021.09.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/13/2021] [Revised: 07/30/2021] [Accepted: 09/13/2021] [Indexed: 11/19/2022] Open
Abstract
In this study, Monte Carlo codes, Geant4 and MCNP6, were used to characterize the fast neutron therapeutic beam produced at iThemba LABS in South Africa. Experimental and simulation results were compared using the latest generation of Silicon on Insulator (SOI) microdosimeters from the Centre for Medical Radiation Physics (CMRP). Geant4 and MCNP6 were able to successfully model the neutron gantry and simulate the expected neutron energy spectrum produced from the reaction by protons bombarding a 9Be target. The neutron beam was simulated in a water phantom and its characteristics recorded by the silicon microdosimeters; bare and covered by a 10B enriched boron carbide converter, at different positions. The microdosimetric quantities calculated using Geant4 and MCNP6 are in agreement with experimental measurements. The thermal neutron sensitivity and production of 10B capture products in the p+ boron-implanted dopant regions of the Bridge microdosimeter is investigated. The obtained results are useful for the future development of dedicated SOI microdosimeters for Boron Neutron Capture Therapy (BNCT). This paper provides a benchmark comparison of Geant4 and MCNP6 capabilities in the context of further applications of these codes for neutron microdosimetry.
Collapse
Affiliation(s)
- James Vohradsky
- Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia
| | - Linh T Tran
- Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia
| | - Susanna Guatelli
- Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia
| | - Lachlan Chartier
- Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia
| | | | | | - Jaime Nieto-Camero
- iThemba Laboratory for Accelerator Based Sciences, Cape Town, South Africa
| | - David Bolst
- Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia
| | - Stefania Peracchi
- Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia
| | - Carina Höglund
- European Spallation Source (ESS), Lund, Sweden; Department of Physics, Thin Film Physics Division, Linköping University, Sweden
| | - Anatoly B Rosenfeld
- Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia.
| |
Collapse
|
2
|
Ebner DK, Malouff TD, Frank SJ, Koto M. The Role of Particle Therapy in Adenoid Cystic Carcinoma and Mucosal Melanoma of the Head and Neck. Int J Part Ther 2021; 8:273-284. [PMID: 34285953 PMCID: PMC8270088 DOI: 10.14338/ijpt-d-20-00076] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2020] [Accepted: 02/11/2021] [Indexed: 12/24/2022] Open
Abstract
Particle irradiation is suitable for resistant histologies owing to a combination of improved dose delivery with potential radiobiologic advantages in high linear energy transfer radiation. Within the head and neck, adenoid cystic carcinoma and mucosal melanoma are two such histologies, being radioresistant and lying closely proximal to critical structures. Here, we review the use of particle irradiation for adenoid cystic carcinoma and mucosal melanoma of the head and neck.
Collapse
Affiliation(s)
- Daniel K Ebner
- Hospital of the National Institutes of Quantum and Radiological Science and Technology (QST Hospital), Chiba, Japan
| | - Timothy D Malouff
- Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA
| | - Steven J Frank
- Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Masashi Koto
- Hospital of the National Institutes of Quantum and Radiological Science and Technology (QST Hospital), Chiba, Japan
| |
Collapse
|
3
|
Lund CM, Famulari G, Montgomery L, Kildea J. A microdosimetric analysis of the interactions of mono-energetic neutrons with human tissue. Phys Med 2020; 73:29-42. [PMID: 32283505 DOI: 10.1016/j.ejmp.2020.04.001] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/30/2019] [Revised: 03/05/2020] [Accepted: 04/02/2020] [Indexed: 10/24/2022] Open
Abstract
Nuclear reactions induced during high-energy radiotherapy produce secondary neutrons that, due to their carcinogenic potential, constitute an important risk for the development of iatrogenic cancer. Experimental and epidemiological findings indicate a marked energy dependence of neutron relative biological effectiveness (RBE) for carcinogenesis, but little is reported on its physical basis. While the exact mechanism of radiation carcinogenesis is yet to be fully elucidated, numerical microdosimetry can be used to predict the biological consequences of a given irradiation based on its microscopic pattern of energy depositions. Building on recent studies, this work investigated the physics underlying neutron RBE by using the microdosimetric quantity dose-mean lineal energy (y‾D) as a proxy. A simulation pipeline was constructed to explicitly calculate the y‾D of radiation fields that consisted of (i) the open source Monte Carlo toolkit Geant4, (ii) its radiobiological extension Geant4-DNA, and (iii) a weighted track-sampling algorithm. This approach was used to study mono-energetic neutrons with initial kinetic energies between 1 eV and 10 MeV at multiple depths in a tissue-equivalent phantom. Spherical sampling volumes with diameters between 2 nm and 1 μm were considered. To obtain a measure of RBE, the neutron y‾D values were divided by those of 250 keV X-rays that were calculated in the same way. Qualitative agreement was found with published radiation protection factors and simulation data, allowing for the dependencies of neutron RBE on depth and energy to be discussed in the context of the neutron interaction cross sections and secondary particle distributions in human tissue.
Collapse
Affiliation(s)
- C M Lund
- Medical Physics Unit, McGill University, Montreal, QC H4A3J1, Canada.
| | - G Famulari
- Medical Physics Unit, McGill University, Montreal, QC H4A3J1, Canada
| | - L Montgomery
- Medical Physics Unit, McGill University, Montreal, QC H4A3J1, Canada
| | - J Kildea
- Medical Physics Unit, McGill University, Montreal, QC H4A3J1, Canada
| |
Collapse
|
4
|
Pignol JP, Lechtman E. Reply to Comment on ‘Implications on clinical scenario of gold nanoparticle radiosensitization in regards to photon energy, nanoparticle size, concentration and location’. Phys Med Biol 2011. [DOI: 10.1088/0031-9155/57/1/291] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
5
|
Garny S, Rühm W, Zankl M, Wagner FM, Paretzke HG. First steps towards a fast-neutron therapy planning program. Radiat Oncol 2011; 6:163. [PMID: 22118299 PMCID: PMC3261826 DOI: 10.1186/1748-717x-6-163] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2011] [Accepted: 11/25/2011] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND The Monte Carlo code GEANT4 was used to implement first steps towards a treatment planning program for fast-neutron therapy at the FRM II research reactor in Garching, Germany. Depth dose curves were calculated inside a water phantom using measured primary neutron and simulated primary photon spectra and compared with depth dose curves measured earlier. The calculations were performed with GEANT4 in two different ways, simulating a simple box geometry and splitting this box into millions of small voxels (this was done to validate the voxelisation procedure that was also used to voxelise the human body). RESULTS In both cases, the dose distributions were very similar to those measured in the water phantom, up to a depth of 30 cm. In order to model the situation of patients treated at the FRM II MEDAPP therapy beamline for salivary gland tumors, a human voxel phantom was implemented in GEANT4 and irradiated with the implemented MEDAPP neutron and photon spectra. The 3D dose distribution calculated inside the head of the phantom was similar to the depth dose curves in the water phantom, with some differences that are explained by differences in elementary composition. The lateral dose distribution was studied at various depths. The calculated cumulative dose volume histograms for the voxel phantom show the exposure of organs at risk surrounding the tumor. CONCLUSIONS In order to minimize the dose to healthy tissue, a conformal treatment is necessary. This can only be accomplished with the help of an advanced treatment planning system like the one developed here. Although all calculations were done for absorbed dose only, any biological dose weighting can be implemented easily, to take into account the increased radiobiological effectiveness of neutrons compared to photons.
Collapse
Affiliation(s)
- Sylvia Garny
- Helmholtz Zentrum München, Institut für Strahlenschutz, Ingolstädter Landstraße 1, 85764 Neuherberg, Germany.
| | | | | | | | | |
Collapse
|
6
|
Lillhök JE, Grindborg JE, Lindborg L, Gudowska I, Carlsson GA, Söderberg J, Kopeć M, Medin J. Nanodosimetry in a clinical neutron therapy beam using the variance-covariance method and Monte Carlo simulations. Phys Med Biol 2007; 52:4953-66. [PMID: 17671346 DOI: 10.1088/0031-9155/52/16/016] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Nanodosimetric single-event distributions or their mean values may contribute to a better understanding of how radiation induced biological damages are produced. They may also provide means for radiation quality characterization in therapy beams. Experimental nanodosimetry is however technically challenging and Monte Carlo simulations are valuable as a complementary tool for such investigations. The dose-mean lineal energy was determined in a therapeutic p(65)+Be neutron beam and in a (60)Co gamma beam using low-pressure gas detectors and the variance-covariance method. The neutron beam was simulated using the condensed history Monte Carlo codes MCNPX and SHIELD-HIT. The dose-mean lineal energy was calculated using the simulated dose and fluence spectra together with published data from track-structure simulations. A comparison between simulated and measured results revealed some systematic differences and different dependencies on the simulated object size. The results show that both experimental and theoretical approaches are needed for an accurate dosimetry in the nanometer region. In line with previously reported results, the dose-mean lineal energy determined at 10 nm was shown to be related to clinical RBE values in the neutron beam and in a simulated 175 MeV proton beam as well.
Collapse
Affiliation(s)
- J E Lillhök
- Swedish Radiation Protection Authority, Stockholm, Sweden
| | | | | | | | | | | | | | | |
Collapse
|
7
|
Abstract
This paper presents the results of a study aimed at investigating the dosimetry of stable dysprosium microspheres activated, in situ, by a linac generated photon beam. In phantom measurements of the neutron flux within an 18 MV photon beam were performed using CR-39 detectors and gold activation. The results were used in conjunction with a Monte Carlo computer simulation to investigate the dose distribution resulting from the activation of dysprosium (Dy) microspheres using an 18 MV photon beam. Different depths, lesion volumes and volume concentrations of microspheres are investigated. The linac lower collimator jaws are assumed completely closed to shield the tumour volume from the photon dose. Using a single AP field with 0 x 0 cm2 field size (closed jaws), a photon dose rate of 600 MU min(-1) and 80 cm SSD for 10 min, an average dose exceeding 1 Gy can be delivered to spherical lesions of 0.5 cm and higher diameter. The variation of the average dose with the size of the lesion reaches saturation for tumour volumes exceeding 1 cm in diameter. This report shows that the photon beam of a high-energy linac can be used to activate Dy microspheres in situ and, as a result, deliver a significant dose of beta radiation. Non-radioactive Dy microspheres do not have the toxicity and imaging problems associated with commercially available yttrium-90 based products.
Collapse
Affiliation(s)
- N Adnani
- NTI Medical Inc., Suite 1150, Manulife Place, 10180-101 Street, Edmonton, Alberta T5J 3S4, Canada
| |
Collapse
|
8
|
Prestwich WV, McNeill FE, Waker AJ. Development of a low-energy monoenergetic neutron source for applications in low-dose radiobiological and radiochemical research. Appl Radiat Isot 2003; 58:629-42. [PMID: 12798371 DOI: 10.1016/s0969-8043(03)00069-1] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
The McMaster University 3 MV KN Van de Graff accelerator facility primarily dedicated to in vivo neutron activation measurements has been used to produce moderate dose rates of monoenergetic fast neutrons of energy ranging from 150 to 600 keV with a small energy spread of about 25 keV (1sigma width of Gaussian) by bombarding thin lithium targets with 2.00-2.40 MeV protons. The calculated dose rate of the monoenergetic neutrons produced using thin lithium targets as functions of beam energy, target thickness, lab angle relative to beam direction, and the solid angle subtended by the sample with the target has also been reported.
Collapse
|
9
|
Langen KM, Binnss PJ, Schreuder AN, Lennox AJ, Deluca PM. Measurement of the tissue to A-150 tissue equivalent plastic kerma ratio at two p(66)Be neutron therapy facilities. Phys Med Biol 2003; 48:1345-59. [PMID: 12812451 DOI: 10.1088/0031-9155/48/10/308] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
The ICRU tissue to A-150 tissue equivalent plastic kerma ratio is needed for neutron therapy dosimetry. The current ICRU protocol for neutron dosimetry recommends using a common conversion factor of 0.95 at all high-energy neutron therapy facilities. In an effort to determine facility specific ICRU tissue to A-150 plastic kerma ratios, an experimental approach was pursued. Four low pressure proportional counters that differed in wall materials (i.e. A-150, carbon, zirconium and zirconium-oxide) were used as dosimeters and integral kerma ratios were determined directly in the clinical beam. Measurements were performed at two p(66)Be facilities: iThemba LABS near Cape Town and Fermilab near Chicago. At the iThemba facility the clinical neutron beam is routinely filtered by a flattening and hardening filter combination. The influence of beam filtration on the kerma ratio was evaluated. Using two recent gas-to-wall dose conversion factor (r(m,g) value) evaluations a mean ICRU tissue to A-150 plastic kerma ratio of 0.93 +/- 0.05 was determined for the clinical beam at iThemba LABS. The respective value for the Fermilab beam is 0.95 +/- 0.05. The experimentally determined ICRU tissue to A-150 plastic kerma ratios for the two clinical beams are in agreement with theoretical evaluations. Beam filtration reduces the kerma ratio by 3 +/- 2%.
Collapse
Affiliation(s)
- K M Langen
- iThemba LABS, Somerset West 7129, South Africa.
| | | | | | | | | |
Collapse
|
10
|
Bourhis-Martin E, Meissner P, Rassow J, Baumhoer W, Schmidt R, Sauerwein W. Validation of a pencil beam model-based treatment planning system for fast neutron therapy. Med Phys 2003; 30:21-6. [PMID: 12557974 DOI: 10.1118/1.1527040] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
Treatment planning systems (TPSs) are used to compute dose delivered to the patient. In the case of fast neutron therapy, TPSs are mostly not of general purpose but are dedicated to one facility. This is due to the few fast neutron facilities worldwide and due to the high variation in the neutron energy distributions. Efforts have been undertaken to develop a new TPS that could be applied to all the existing fast neutron facilities. The University Hospital of Essen operates a d (14 MeV) + Be fast neutron beam and the TPS used is based on an empirical model. In a previous study, the empirical model has been evolved to a pencil beam model of 35 monoenergetic neutron beams. Monte Carlo techniques have been utilized to compute distributions of the energy deposition due to primary and scattered neutrons in a simple geometry water phantom. The experimental validation of the method is now presented. Depth dose curves in water of monoenergetic neutrons have been derived from the distributions of energy deposition. The resultant depth dose curves have been utilized in order to determine the depth dose curves of the fast neutron beam of the Essen facility for the 14 radiation field sizes available in this facility. This determination requires the initial neutron spectrum. As this spectrum could not be measured at the Essen facility, the initial neutron spectrum of the Physikalisch Technische Bundesanstalt, Braunschweig, Germany, which operates the same cyclotron, was used. The calculated depth dose curves were compared to experimental depth dose curves that have been obtained in water at the University Hospital of Essen. The comparison between calculated and experimental depth dose curves showed significant deviations in the case of large radiation fields and of depth less than 5 cm. In the case of radiation field areas less than 150 cm2 and depth more than 5 cm (usual clinical situation), the measured and calculated values are in a good agreement. In the case of clinical situation, the dependence on the radiation field size is relatively well taken into account by the model presented here.
Collapse
Affiliation(s)
- E Bourhis-Martin
- Strahlenklinik, Universitätsklinikum Essen, 45122 Essen, Germany.
| | | | | | | | | | | |
Collapse
|
11
|
Adnani N. Vascular in situ activation radiation therapy insitustent dosimetry. CARDIOVASCULAR RADIATION MEDICINE 2002; 3:193-8. [PMID: 12974373 DOI: 10.1016/s1522-1865(03)00103-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
PURPOSE To investigate the radiation dosimetry of a stable stent following activation by a linac photon beam. METHODS AND MATERIALS A computer simulation is used in conjunction with neutron measurements to study the dosimetry of a stent activated by a linac photon beam. Two models are investigated. A gamma emitter, Model G108, with no half-life and 1.43 MeV average energy, and a beta emitter, Model D108, with 2.33 h half-life and 0.45 MeV average energy. RESULTS Model D108 delivers a dose exceeding 1 Gy to the artery wall when exposed to an 18-MV photon beam. Model G108 requires a 25-MV photon beam to deliver a similar dose under the same conditions of irradiation. CONCLUSION The very short to no half-life of InSituStent emissions makes the fractionation of the dose delivery possible. In addition, an InSituStent coated with an immunosuppressant drug may give patients the potential benefit of a combined radiation and drug treatments.
Collapse
Affiliation(s)
- N Adnani
- NTI Medical Inc., Suite 1150, Manulife Place, 10180-101 Street, Edmonton, Alberta, Canada T5J 3S4.
| |
Collapse
|